Letter from the CEO
It has been a year and ten months since the World Health Organization declared COVID-19 a pandemic. Despite the continuing pandemic, VIC’s business has largely returned to normal albeit with increased remote work, more...
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
Recently, the medical device and diagnostics sectors have seen considerable disruption. Common medical devices used in disease detection and treatment, for example, imaging systems such as X-ray and MRI machines, CT-...
VIC Fellows Spotlight: Kelly Mabry, PhD
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...
VIN Partner Profile: Carol Reeves
Could you tell us a little bit about your background and experience? I grew up on a tiny farm in Fayetteville, Georgia. Because my family was poor, my siblings and I were always trying to figure out ways to make money....
Nob Hill Therapeutics Announces Strategic Advisory Board to Accelerate Growth
Nob Hill Therapeutics has recruited global thought leaders to its Strategic Advisory Board. Albuquerque, NM - Nob Hill Therapeutics (NHT) is pleased to announce the members of its Strategic Advisory Board. Under the...
Inside UCSF Innovation Ventures with Executive Director, Anthony Francis
Tell us about UCSF and what sets your institution apart? The simple answer to that question would be it’s the scientific research coupled with our focus on practical healthcare. At the University of California, San...
VIC Technology Venture Development Adds Laura Lyons to Board of Directors
Medtech veteran adds further quality, regulatory, and clinical experience FAYETTEVILLE, AR- VIC Technology Venture Development has announced the appointment of Laura Lyons, who brings 20 years of executive leadership...
Nob Hill Therapeutics to Present at Partnership Opportunities in Drug Delivery (PODD) Conference
Nob Hill Therapeutics' Executive Chairman Paul Atkins will be presenting at the Partnership Opportunities in Drug Delivery (PODD) conference during the DryNeb – Advancing Pulmonary Drug Delivery session on Friday,...
Akeso Biomedical Receives EU Authorization for CI-FER® as a Feed Additive in Piglets
CI-FER® reduces pathogen biofilms leading to improved zootechnical performance. BURLINGTON, MA – Akeso Biomedical, Inc., announced today that the company has obtained authorization in the European Union to market...
Impact Investing in Healthcare
During the past several years, the somewhat overlapping concepts of Impact Investing and Environmental, Social and Governance (ESG) are increasingly top of mind for everyday investors. Impact Investing refers to...
